InvestorsHub Logo
Followers 45
Posts 1513
Boards Moderated 0
Alias Born 11/25/2013

Re: None

Monday, 11/30/2020 7:59:00 AM

Monday, November 30, 2020 7:59:00 AM

Post# of 425975
The primary investigator for the Argentina Vascepa Covid trial just sent me a direct email saying he read my document and “FULLY AGREES WITH MY CONCEPTS”. This guy is an expert in EPA chemistry and cardiovascular medicine. His support is a strong indicator that WE ARE RIGHT. HOLD STRONG AND WAIT FOR DECEMBER 12. Positive effects on COVID and the trial loss COULD ACTUALLY BE A GOOD THING! Seriously, if we won on March 30 and then JT sold for $40 we could have missed the boat from benefits from CURING A WORLDWIDE PANDEMIC! The benefits go beyond COVID (the annual flu, sepsis, other infections and inflammatory conditions etc). Losing could turn out to be a GOOD thing.
Patience!

https://drive.google.com/file/d/1Itb_xXZhtTZgfhx7Q3xcgcy5dPN3Hhr5/view?usp=drivesdk

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News